Cognoptix CEO Dr. Susanne Wilke to Present at the 13th Annual BIOTECH SHOWCASE™ DIGITAL Event
Cognoptix, a privately-held, diagnostics company with a breakthrough technology for the early detection of Alzheimer’s disease (AD), announces that the company will present at the 13th Annual Biotech Showcase™ Digital Event, January 11-15, 2021. Read more >>